… AS02 A vaccine had a good safety profile, was well-tolerated, and induced high and … in
malaria-exposed children. This malaria vaccine is being evaluated in a Phase 2 efficacy trial in …

… to malaria vaccine development. We aimed to develop a genetically attenuated blood-stage
vaccine and test its safety, … -stage GAP malaria vaccine and characterize its safety, infectivity, …

… goal for a modestly efficacious malaria vaccine yielding … vaccine candidate now under
regulatory and policy review. There are three general approaches to developing malaria vaccines, …

… The malaria vaccine candidate, RTS,S/AS01 E , showed promising protective efficacy in a …
Here we report on the vaccine's safety and tolerability. The experimental design was a Phase …

… We aimed to assess the safety, immunogenicity, and initial efficacy of the malaria vaccine …
In this paper, we report the results of the first evaluation of safety, immunogenicity, and efficacy …

… This paper reports the results of the first field study performed to assess the safety,
immunogenicity and protectivity of the synthetic malaria vaccine SPf66 directed against the asexual …

… malaria occurs in young children [5]. In order to ultimately evaluate the safety and efficacy of
the RTS,S/AS02A candidate vaccine … escalation and dose escalation safety trials in children. …

… interventions, including vaccines to prevent … malaria vaccine development efforts, with
particular emphasis on the impact of the possible availability of a first generation malaria vaccine …

… for other diseases are being evaluated first in malaria. We describe progress in malaria
vaccine development in the past 5 years: reasons for cautious optimism, the type of vaccine that …

… a consultation with the malaria vaccine community and leading statisticians that helped
reassure that the methodologies that we have used in our malaria vaccine field trials and the …